These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

As Hain Celestial gears up for a potential disposal of its personal-care business to become a “pure play” food and beverage ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

With nearly half of Americans saying weight loss ... care provider if it is interfering with your daily life. Feeling tired during GLP-1 treatment is common as your body adjusts to taking in ...

making it the product with the longest half-life among all GLP-1 drugs in the global market so far," said Wang Qinghua, founder of Innogen. He added that data from clinical trials showed that in ...

All the participants, who were followed for a median of about three-and-a-half years, had type 2 diabetes. About 215,000 used GLP-1 drugs, while the rest were taking various other diabetes ...

Advancing GLP-1 Therapies Current GLP-1 drugs for diabetes and obesity management often require frequent injections due to their short half-life. In just two weeks, IPA's LENS ai generated ...